Industry Overview

North American Medical Device Technology Market was valued at $190.3 billion in 2025 and is projected to reach $299.2 billion by 2035, growing at a CAGR of 4.7% during the forecast period (2026–2035). The medical device market in North America continues to strengthen as healthcare providers focus on improving diagnostic accuracy, treatment precision, and patient outcomes. Hospitals and outpatient centers are steadily upgrading to advanced imaging platforms, automated testing systems, and minimally invasive therapeutic devices. The rising prevalence of chronic diseases and an aging population are contributing to higher demand for technologies that support early intervention and efficient care delivery. Strong R&D capabilities and active collaboration among manufacturers, research institutions, and clinical networks are also driving steady innovation. Regulatory support for safer and more effective devices further reinforces the region’s momentum. Together, these factors are shaping a market that is expanding in both scale and technological sophistication.

Market Dynamics

Growing Integration of Digital and Connected Technologies

The global medical device landscape is steadily shifting toward connected platforms that support real-time monitoring, remote diagnostics, and data-driven clinical decisions. Wearable sensors, cloud-linked diagnostic tools, and smart imaging systems are gaining wider acceptance as providers work to improve care continuity and reduce hospital burdens. Manufacturers are increasingly embedding analytics and AI features to enhance accuracy and streamline clinical workflows. This shift is also supported by the broader adoption of telehealth, which relies heavily on interoperable and secure device ecosystems. As digital capabilities mature, connected technologies are becoming central to how healthcare systems manage patient care globally.

Rising Demand for Minimally Invasive and Precision-Based Devices

The market is seeing sustained momentum in therapeutic devices designed to reduce recovery time and improve procedural outcomes. Cardiology, orthopedics, and ophthalmology continue to lead this shift as clinicians adopt advanced implants, robotic-assisted tools, and image-guided systems. Growing surgical volumes and an expanding elderly population are further driving the need for precision-engineered solutions. Companies are investing in smaller, more adaptable devices suitable for complex yet less invasive procedures. Recent trends also highlight increased collaboration between hospitals and manufacturers to refine device performance and optimize patient pathways. This ongoing transition underscores the global preference for safer, faster, and more effective treatment options.

Market Segmentation

• Based on the device type, the market is segmented into in vitro diagnostics devices, diagnostic imaging devices, cardiology devices, ophthalmology devices, orthopedic devices, and others.

In Vitro Diagnostics Devices Segment to Lead the Market with the Largest Share

The in vitro diagnostics segment in North America continues to expand as healthcare providers rely more heavily on rapid and accurate testing to manage rising chronic and infectious diseases. Growth is supported by widespread use of molecular assays, point-of-care systems, and automated high-throughput platforms across hospital and reference laboratories. The key market players, such as Abbott, Roche, Thermo Fisher Scientific, and Beckman Coulter, are introducing advanced solutions that shorten turnaround times and improve workflow efficiency. The region is also investing in modern lab infrastructure and interoperable data systems to enhance clinical reporting. Recent activity includes broader adoption of AI-aided interpretation tools that support faster and more precise diagnostic decisions. These developments continue to reinforce the segment’s central role in improving patient management.

Diagnostic Devices: A Key Segment in Market Growth

Diagnostic imaging remains one of the most dynamic categories in North America as hospitals and specialty centers consistently upgrade to advanced MRI, CT, ultrasound, and digital X-ray systems. Higher screening volumes, an aging population, and demand for clearer and more timely imaging are driving steady adoption of new technologies. Leading companies such as GE HealthCare, Siemens Healthineers, Philips, and Canon Medical continue to strengthen the market with improved imaging clarity, lower radiation systems, and more compact designs for outpatient settings. Cloud-based archiving and remote reading tools are becoming more common, helping facilities streamline radiology workflows. Recent trends also point to growing interest in AI-supported image analysis to reduce interpretation time and detect abnormalities earlier. These advancements are setting the stage for continued growth across the region’s imaging landscape.

Regional Outlook

The North American Medical Device Technology Market is further divided by countries, including the US and Canada.

US Dominates the Market with Major Share

The US remains the core driver of medical device advancements, supported by strong R&D ecosystems, high healthcare spending, and rapid adoption of next-generation technologies. Hospitals and specialty centers continue to invest in advanced diagnostics, precision imaging, and minimally invasive therapeutic systems to meet rising patient needs. Major players such as Medtronic, Abbott, Boston Scientific, GE HealthCare, and Johnson & Johnson maintain a dominant presence through continuous product development and clinical partnerships. The country is also seeing increased interest in AI-enabled platforms, connected devices, and robotics to enhance clinical workflows. Recent activity highlights the broader integration of digital tools that improve patient monitoring and streamline care delivery. These factors keep the US at the forefront of regional market expansion.

Market Players Outlook

The major companies operating in the North American Medical Device Technology Market include Medtronic plc, Abbott Laboratories, GE HealthCare, Boston Scientific Corp., and Stryker Corp., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

• In March 2025, GE HealthCare announced the US launch of Flyrcado (flurpiridaz F 18) injection at the 2025 American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place March 29-31 in Chicago. Additionally, the company will showcase new AI-powered innovations, reflecting its strategy to leverage AI to help increase efficiency and enable seamless integration of data across the cardiology care pathway. GE HealthCare has been investing in AI for years and has topped the FDA list of AI-enabled device authorizations for three years in a row with 85 authorizations.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the North American Medical Device Technology Market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.